A photoelectrochemical biosensor using ruthenium complex-reduced graphene oxide hybrid as the photocurrent signal reporter assembled on rhombic TiO2 nanocrystals driven by visible light

An ultrasensitive photoelectrochemical (PEC) immunoassay of cancer biomarker carcinoembryonie antigen (CEA) is proposed that uses rhombic titanium dioxide nanocrystals (TiO₂ NCs) coupled with Ab2–RGO-Ru bioconjugate, which featured CEA signal antibody (Ab2) and ruthenium tris(bipyridine) (Ru complex) labels linked to reduced graphene oxide (RGO) for signal amplification. Herein, the Ru complex acts as an electron donor, while RGO serves as an electron acceptor which facilitates charge separation and suppresses recombination of photoexcited electron–hole pairs in the hybridized species. The rhombic TiO₂ NCs were fabricated through a solvothermal technique in anhydrous ethanol, followed by spin-coating process and calcination, an ITO/TiO₂ electrode was obtained. Chitosan (CS) and glutaraldehyde (GLD) were used to modify the prepared ITO/TiO₂ electrode to covalently immobilize antibodies. With a sandwich-type immunoreaction, CEA and Ab2–RGO-Ru were conjugated successively to form a sandwich-type immunocomplex. Thus, a sandwich-type PEC immunosensor was fabricated for the detection of CEA was developed by monitoring the changes in the photocurrent signals of the electrode resulting from the immunoreaction. The proposed PEC immunosensor showed high sensitivity, selectivity, excellent stability, and good reproducibility, and thus has great potential to be used for other biological assays.